Aim & Scope
Clinical Trials and Bioavailability Research covers a broad spectrum of topics related to clinical trials, bioavailability, pharmacokinetics, pharmacodynamics, drug delivery systems, and related disciplines. The journal welcomes submissions encompassing, but not limited to, the following areas:
- Clinical Trial Design and Methodology: Novel approaches and methodologies for the design, conduct, and analysis of clinical trials across various phases (Phase I-IV), including randomized controlled trials, observational studies, and adaptive trial designs.
- Bioavailability and Pharmacokinetics: Studies investigating the absorption, distribution, metabolism, and excretion (ADME) of drugs, as well as factors influencing bioavailability, such as drug formulations, drug interactions, and patient-specific variables.
- Drug Delivery Systems: Development and evaluation of innovative drug delivery systems, including nanoparticles, liposomes, microparticles, and implants, aimed at optimizing drug bioavailability, targeting specific tissues, and enhancing therapeutic efficacy.
- Pharmacogenetics and Personalized Medicine: Research exploring the role of genetic variation in drug response and metabolism, as well as strategies for integrating pharmacogenetic information into clinical practice to optimize treatment outcomes and minimize adverse effects.
- Clinical Pharmacology and Therapeutics: Studies investigating the pharmacological properties of drugs, dose-response relationships, therapeutic drug monitoring, and strategies for individualizing drug therapy based on patient characteristics and disease state.
- Regulatory Science and Drug Development: Articles addressing regulatory requirements for the conduct of clinical trials, drug approval processes, post-marketing surveillance, and pharmacovigilance, with a focus on promoting patient safety and ensuring the quality and efficacy of pharmaceutical products.
- Clinical Outcomes and Health Economics: Assessments of clinical outcomes, patient-reported outcomes, quality of life measures, and cost-effectiveness analyses of healthcare interventions, with implications for clinical decision-making and resource allocation.
We invite original research articles, reviews, brief communications, case studies, and commentaries that contribute to advancing knowledge in the field of clinical trials and bioavailability research. Our journal provides a platform for interdisciplinary collaboration and dialogue among researchers, clinicians, industry professionals, regulatory authorities, and policymakers, with the ultimate goal of improving patient care and advancing public health.
